Literature DB >> 10574697

Production of carcinoembryonic antigen (CEA) N-A3 domain in Pichia pastoris by fermentation.

S Hellwig1, F Robin, J Drossard, N P Raven, C Vaquero-Martin, J E Shively, R Fischer.   

Abstract

Carcinoembryonic antigen (CEA) is a 180-kDa glycoprotein found on the surface of normal colon and malignant human adenocarcinomas. Recently, a fusion protein containing two of the seven Ig-like domains present in CEA (N and A3) has been constructed and expressed in Pichia pastoris [You, Hefta, Yazaki, Wu and Shively (1998) Anticancer Res. 18, 3193-3201]. Here, we report the generation and selection of a multi-copy clone expressing this fusion protein, the optimization of the shake-flask expression protocol and the upscaled production of CEA N-A3 using fermentation technology. P. pastoris transformants secreting the CEA N-A3 domain were generated by electrotransformation of the GS115 host strain with the pPIC9K vector containing the CEA N-A3 cDNA [You, Hefta, Yazaki, Wu and Shively (1998) Anticancer Res. 18, 3193-3201] then screened for CEA N-A3 expression and G418 resistance. The recombinant CEA N-A3 domain was detected in the culture supernatant using the monoclonal anti-CEA antibody T84.66. Optimization of methanol-induction conditions resulted in a high-methanol shake-flask expression protocol yielding significantly increased CEA N-A3 levels. Fermentation and culture conditions were optimized for 5-l working-volume fermentations and CEA N-A3 was affinity purified using Ni-IDA (imino di-acetic acid) affinity chromatography from the clarified fermentation supernatant. Peptide N-glycosidase F treatment revealed that the recombinant protein was heavily glycosylated but expressed as a single polypeptide of 28 kDa with no evidence of proteolytic degradation. Our results demonstrate that functional CEA N-A3 domain can be produced in sufficient quantities in P. pastoris for structural analysis or diagnostic applications. To our knowledge, this article represents the first report on the production of a human tumour antigen through fermentation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574697

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  7 in total

1.  A subfamily of Dr adhesins of Escherichia coli bind independently to decay-accelerating factor and the N-domain of carcinoembryonic antigen.

Authors:  Natalia Korotkova; Ernesto Cota; Yuri Lebedin; Severine Monpouet; Julie Guignot; Alain L Servin; Steve Matthews; Steve L Moseley
Journal:  J Biol Chem       Date:  2006-08-01       Impact factor: 5.157

2.  Biochemical properties of the matrix metalloproteinase NtMMP1 from Nicotiana tabacum cv. BY-2 suspension cells.

Authors:  Manoj K Mandal; Rainer Fischer; Stefan Schillberg; Andreas Schiermeyer
Journal:  Planta       Date:  2010-07-16       Impact factor: 4.116

3.  Simple enzymatic procedure for L-carnosine synthesis: whole-cell biocatalysis and efficient biocatalyst recycling.

Authors:  Jan Heyland; Nicolai Antweiler; Jochen Lutz; Tobias Heck; Birgit Geueke; Hans-Peter E Kohler; Lars M Blank; Andreas Schmid
Journal:  Microb Biotechnol       Date:  2009-08-04       Impact factor: 5.813

4.  Comprehensive clone screening and evaluation of fed-batch strategies in a microbioreactor and lab scale stirred tank bioreactor system: application on Pichia pastoris producing Rhizopus oryzae lipase.

Authors:  Johannes Hemmerich; Núria Adelantado; José Manuel Barrigón; Xavier Ponte; Astrid Hörmann; Pau Ferrer; Frank Kensy; Francisco Valero
Journal:  Microb Cell Fact       Date:  2014-03-07       Impact factor: 5.328

5.  IMAC capture of recombinant protein from unclarified mammalian cell feed streams.

Authors:  Alexander Kinna; Berend Tolner; Enrique Miranda Rota; Nigel Titchener-Hooker; Darren Nesbeth; Kerry Chester
Journal:  Biotechnol Bioeng       Date:  2015-09-03       Impact factor: 4.530

6.  Improvement of a fermentation process for the production of two PfAMA1-DiCo-based malaria vaccine candidates in Pichia pastoris.

Authors:  Robin Kastilan; Alexander Boes; Holger Spiegel; Nadja Voepel; Ivana Chudobová; Stephan Hellwig; Johannes Felix Buyel; Andreas Reimann; Rainer Fischer
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

7.  Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation.

Authors:  Bart W Faber; Stephan Hellwig; Sophie Houard; Nicolas Havelange; Jürgen Drossard; Hubert Mertens; Alexander Croon; Robin Kastilan; Richard Byrne; Nicole van der Werff; Marjolein van der Eijk; Alan W Thomas; Clemens H M Kocken; Edmond J Remarque
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.